Sen. Grassley Considering Tighter Securities Laws To Prevent Clinical Trial Disclosure
This article was originally published in The Pink Sheet Daily
Executive Summary
Letter to the Department of Justice and the Securities & Exchange Commission requests an investigation into allegations of insider trading.